Non-coding RNA Delivery for Bone Tissue Engineering: Progress, Challenges, and Potential Solutions

Overview

Journal iScience

Publisher Cell Press

Date 2022 Aug 22

PMID 35992068

Authors

Shiyao Guan

Zhen Zhang

Jun Wu

Affiliations

Soon will be listed here.

Abstract

More than 20 million individuals worldwide suffer from congenital or acquired bone defects annually. The development of bone scaffold materials that simulate natural bone for bone defect repair remains challenging. Recently, ncRNA-based therapies for bone defects have attracted increasing interest because of the great potential of ncRNAs in disease treatment. Various types of ncRNAs regulate gene expression in osteogenesis-related cells via multiple mechanisms. The delivery of ncRNAs to the site of bone loss through gene vectors or scaffolds is a potential therapeutic option for bone defect repair. Therefore, this study discusses and summarizes the regulatory mechanisms of miRNAs, siRNAs, and piRNAs in osteogenic signaling and reviews the widely used current RNA delivery vectors and scaffolds for bone defect repair. Additionally, current challenges and potential solutions of delivery scaffolds for bone defect repair are proposed, with the aim of providing a theoretical basis for their future clinical applications.

Citing Articles

Integrating Micro- and Nanostructured Platforms and Biological Drugs to Enhance Biomaterial-Based Bone Regeneration Strategies.

Shah S, Sohail M, Nakielski P, Rinoldi C, Zargarian S, Kosik-Koziol A Biomacromolecules. 2024; 26(1):140-162.

PMID: 39621708 PMC: 11733931. DOI: 10.1021/acs.biomac.4c01133.

Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine.

Castanon-Cortes L, Bravo-Vazquez L, Santoyo-Valencia G, Medina-Feria S, Sahare P, Duttaroy A Front Bioeng Biotechnol. 2024; 12:1484151.

PMID: 39479296 PMC: 11521876. DOI: 10.3389/fbioe.2024.1484151.

Noncoding RNAs: the crucial role of programmed cell death in osteoporosis.

Han J, Zhu Y, Zhang J, Kapilevich L, Zhang X Front Cell Dev Biol. 2024; 12:1409662.

PMID: 38799506 PMC: 11116712. DOI: 10.3389/fcell.2024.1409662.

Bone-nerve crosstalk: a new state for neuralizing bone tissue engineering-A mini review.

Damiati L, El Soury M Front Med (Lausanne). 2024; 11:1386683.

PMID: 38690172 PMC: 11059066. DOI: 10.3389/fmed.2024.1386683.

BioDeepfuse: a hybrid deep learning approach with integrated feature extraction techniques for enhanced non-coding RNA classification.

Avila Santos A, de Almeida B, Bonidia R, Stadler P, Stefanic P, Mandic-Mulec I RNA Biol. 2024; 21(1):1-12.

PMID: 38528797 PMC: 10968306. DOI: 10.1080/15476286.2024.2329451.

References

Wei S, Ma J, Xu L, Gu X, Ma X . Biodegradable materials for bone defect repair. Mil Med Res. 2020; 7(1):54. PMC: 7653714. DOI: 10.1186/s40779-020-00280-6. View

Liu J, Chen M, Ma L, Dang X, Du G . piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification. Aging (Albany NY). 2021; 13(19):23361-23375. PMC: 8544320. DOI: 10.18632/aging.203630. View

Li Y, Chen G, He Y, Yi C, Zhang X, Zeng B . Selenomethionine-Modified Polyethylenimine-Based Nanoparticles Loaded with miR-132-3p Inhibitor-Biofunctionalized Titanium Implants for Improved Osteointegration. ACS Biomater Sci Eng. 2021; 7(10):4933-4945. DOI: 10.1021/acsbiomaterials.1c00880. View

Zhang Y, Gao Y, Cai L, Li F, Lou Y, Xu N . MicroRNA-221 is involved in the regulation of osteoporosis through regulates RUNX2 protein expression and osteoblast differentiation. Am J Transl Res. 2017; 9(1):126-135. PMC: 5250709. View

Kato C, Kojima T, Komaki M, Mimori K, Duarte W, Takenaga K . S100A4 inhibition by RNAi up-regulates osteoblast related genes in periodontal ligament cells. Biochem Biophys Res Commun. 2004; 326(1):147-53. DOI: 10.1016/j.bbrc.2004.11.010. View

Bellavia D, Salamanna F, Raimondi L, De Luca A, Carina V, Costa V . Deregulated miRNAs in osteoporosis: effects in bone metastasis. Cell Mol Life Sci. 2019; 76(19):3723-3744. PMC: 11105262. DOI: 10.1007/s00018-019-03162-w. View

Barile L, Vassalli G . Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017; 174:63-78. DOI: 10.1016/j.pharmthera.2017.02.020. View

Chen S, Ben S, Xin J, Li S, Zheng R, Wang H . The biogenesis and biological function of PIWI-interacting RNA in cancer. J Hematol Oncol. 2021; 14(1):93. PMC: 8199808. DOI: 10.1186/s13045-021-01104-3. View

Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H . The emerging role of the piRNA/piwi complex in cancer. Mol Cancer. 2019; 18(1):123. PMC: 6688334. DOI: 10.1186/s12943-019-1052-9. View

10.

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

11.

Picanco-Castro V, Pereira C, Covas D, Porto G, Athanassiadou A, Figueiredo M . Emerging patent landscape for non-viral vectors used for gene therapy. Nat Biotechnol. 2020; 38(2):151-157. PMC: 7308177. DOI: 10.1038/s41587-019-0402-x. View

12.

Lolli A, Sivasubramaniyan K, Vainieri M, Oieni J, Kops N, Yayon A . Hydrogel-based delivery of antimiR-221 enhances cartilage regeneration by endogenous cells. J Control Release. 2019; 309:220-230. DOI: 10.1016/j.jconrel.2019.07.040. View

13.

Kharaghani D, Gitigard P, Ohtani H, Kim K, Ullah S, Saito Y . Design and characterization of dual drug delivery based on in-situ assembled PVA/PAN core-shell nanofibers for wound dressing application. Sci Rep. 2019; 9(1):12640. PMC: 6718412. DOI: 10.1038/s41598-019-49132-x. View

14.

McMillan A, Nguyen M, Huynh C, Sarett S, Ge P, Chetverikova M . Hydrogel microspheres for spatiotemporally controlled delivery of RNA and silencing gene expression within scaffold-free tissue engineered constructs. Acta Biomater. 2021; 124:315-326. PMC: 7990721. DOI: 10.1016/j.actbio.2021.01.013. View

15.

Wang X, Thomsen P . Mesenchymal stem cell-derived small extracellular vesicles and bone regeneration. Basic Clin Pharmacol Toxicol. 2020; 128(1):18-36. PMC: 7820981. DOI: 10.1111/bcpt.13478. View

16.

Hajj K, Ball R, Deluty S, Singh S, Strelkova D, Knapp C . Branched-Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH. Small. 2019; 15(6):e1805097. DOI: 10.1002/smll.201805097. View

17.

Yamashiro H, Siomi M . PIWI-Interacting RNA in Drosophila: Biogenesis, Transposon Regulation, and Beyond. Chem Rev. 2017; 118(8):4404-4421. DOI: 10.1021/acs.chemrev.7b00393. View

18.

Tenchov R, Bird R, Curtze A, Zhou Q . Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021; 15(11):16982-17015. DOI: 10.1021/acsnano.1c04996. View

19.

Kong C, Steffi C, Shi Z, Wang W . Development of mesoporous bioactive glass nanoparticles and its use in bone tissue engineering. J Biomed Mater Res B Appl Biomater. 2018; 106(8):2878-2887. DOI: 10.1002/jbm.b.34143. View

20.

Huynh C, Zheng Z, Nguyen M, McMillan A, Tonga G, Rotello V . Cytocompatible Catalyst-Free Photodegradable Hydrogels for Light-Mediated RNA Release To Induce hMSC Osteogenesis. ACS Biomater Sci Eng. 2021; 3(9):2011-2023. DOI: 10.1021/acsbiomaterials.6b00796. View